aan welke wetenschappelijke publicaties hebben medewerkers van het cbg in 2010 (mee) gewerkt?
Hieronder staat een overzicht van wetenschappelijke publicaties
waaraan CBG-medewerkers hebben (mee)gewerkt in 2010. Deze
publicaties hoeven niet noodzakelijkerwijs de mening van het
CBG te reflecteren.
Influence of intensive versus conventional glucose control
on microvascular and macrovascular complications in type 1 and 2
diabetes mellitus.
Mattila T.K., de Boer A.
Drugs. 2010 Dec 3;70(17):2229-45
Comparison of methods for identifying patients
at risk of medication-related harm
Jasperien E van Doormaal, Mirjam K Rommers, Jos G W Kosterink,
Irene M Teepe-Twiss, Flora M Haaijer-Ruskamp, Peter G M Mol
Qual Saf Health Care doi:10.1136/qshc.2009.033324
Computerized physician order entry (CPOE)
system: expectations and experiences of users
Jasperien E. Van Doormaal PharmD, Peter G. M. Mol PhD, et al.
Journal of Evaluation in Clinical Practice, Volume 16, Issue 4,
pages 738–743, August 2010, DOI:
10.1111/j.1365-2753.2009.01187.x
Vergelijking van potentiële risicofactoren voor
medicatiefouten met en zonder schade
Rianne Zaal, Jasperien van Doormaal, Bertil Lenderink, Peter Mol
PhD, Jos Kosterink
Comparison of potential risk factors for
medication errors with and
without patient harm
Rianne J. Zaal, Jasperien E. van Doormaal, Albert W. Lenderink,
Peter G. M. Mol, et al.
Pharmacoepidemiology and Drug Safety, Volume 19, Issue 8, pages
825–833, August 2010, DOI: 10.1002/pds.1977
Is dit vaccin schadelijk?
L. Wijnans, H. Brandt-Dominicus, T. van Rossum, B. Voordouw
Ned Tijdschr Med Microbiol 2010, jaargang 18, nr.3
Stem Cell Therapy – Evaluation of Risk
Factors
C.A. Herberts, M.S.G. Kwa, H.P.H. Hermsen
RIVM Letter Report 360060002/2010 January 2010
Guidance prepared on Stem cells
SCRIP World Pharmaceutical News, 16 april, 2010, No
3492
Isotretinoin use and compliance with the Dutch Pregnancy
Prevention Programme: a retrospective cohort study in females of
reproductive age using pharmacy dispensing data.
Teichert M, Visser LE, Dufour M, Rodenburg E, Straus SM, De Smet
PA, Stricker BH.
Drug Saf. 2010 Apr 1;33(4):315-26
The association of serum testosterone levels and
ventricular repolarization.
van Noord C, Dörr M, Sturkenboom MC, Straus SM, Reffelmann T, Felix
SB, Hofman A, Kors JA, Haring R, de Jong FH, Nauck M, Uitterlinden
AG, Wallaschofski H, Witteman JC, Völzke H, Stricker BH.
Eur J Epidemiol. 2010;25(1):21-8
Mapping the Safety Profile of Biologicals: A
disproportionality analysis using the WHO Adverse Drug Reaction
Database, VigiBase
Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K; Meyboom, Ronald H.B.;
Straus, Sabine M.J.M.; Leufkens, Hubert G.M.; Egberts, Toine
C.G.
Drug Safety: 1 October 2010 - Volume 33 - Issue 10 - pp
865-878
.
Non-cardiovascular drugs that inhibit
hERG-encoded potassium channels and risk of sudden cardiac
death.
C. van Noord, M.C. Sturkenboom, S.M. Straus, J.C.
Witteman, B.H. Stricker.
Heart 2011 Feb; 97(3): p. 215-220 – Epub: 2010 April
Serum glucose and insulin are associated with
QTc and RR intervals in non-diabetic elderly.
C. van
Noord, M. Sturkenboom, S. Straus, A. Hofman, J. Kors, J.
Witteman, B. Stricker.
Eur J Endocrinol 2010; 162: pp 241-248
Insomnia medication: Do published studies
reflect the complete picture of efficacy and
safety?
Taina Mattila, Violeta Stoyanova, André Elferink, Christine
Gispen-de Wied, Anthonius de Boer, Tamar Wohlfarth
European Neuropsychopharmacology
doi:10.1016/j.physletb.2003.10.071
Mapping the Safety Profile of Biologicals - A
Disproportionality Analysis Using the WHO Adverse Drug Reaction
Database, VigiBase
Thijs J. Giezen, Aukje K.
Mantel-Teeuwisse, Ronald H.B. Meyboom, Sabine M.J.M. Straus, Hubert
G.M. Leufkens and Toine C.G. Egberts
Drug Saf. 2010 Oct 1;33(10):865-78. doi:
10.2165/11538330-000000000-00000.
Effects of the Pharmaceutical Technologic Aspects of Oral
Pediatric Drugs on Patient-Related Outcomes: A Systematic
Literature Review
Diana A. van Riet-Nales, Alfred F.A.M. Schobben, Toine C.G.
Egberts, and Carin M.A. Rademaker
Clinical Therapeutics/Volume 32, Number 5,
2010
The EU paediatric regulation Effects on psychopharmacology in
Europe
Stoyanova-Beninska VV, Wohlfarth T, Isaac M, Kalverdijk LJ, van den
Berg H, Gispen-de Wied C (2010) Eur Neuropsychopharmacology
(July 9, Epub)
Compliance with Pregnancy Prevention Programs of isotretinoin in
Europe: a systematic review
H.J.M.J. Crijns, S.M. Straus, C.h. Gispen-de Wied, L.T.W De
Jong-van den Berg
British Journal of Dermatology: 29 July 2010 | DOI:
10.1111/j.1365-2133.2010.09976.x
Safety-Related Regulatory Actions for Orphan
Drugs in the US and EU: A Cohort Study
Heemstra, Harald E.; Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.;
de Vrueh, Remco L.A.; Leufkens, Hubert G.M.
Drug Safety: 1 February 2010 - Volume 33 - Issue 2 - pp
127-137, doi: 10.2165/11319870-000000000-00000
A Decade of Safety-Related Regulatory Action in
the Netherlands - A Retrospective Analysis of Direct
Healthcare Professional Communications from 1999 to 2009
Peter G.M. Mol, Sabine M.J.M. Straus, Sigrid Piening, Jonie T.N. de
Vries, Pieter A. de Graeff and Flora M. Haaijer-Ruskamp
Drug Safety: 1 June 2010 - Volume 33 - Issue 6 - pp 463-474 |
doi: 10.2165/11532840-000000000-00000
Beoordeling en bewaking van geneesmiddelen (pdf)
J. Nuver, M. Lagendijk
AIOS, jaargang 21, juni 2010
Regulatory scientific
advice in drug development: does company size make a
difference?
Putzeist M, Mantel-Teeuwisse A.K., Gispen-De Wied C.C., Hoes A.W.,
Leufkens H.G.M.
Eur J Clin Pharmacol. 2011 Feb; 67(2):157-64.Epub 2010 Nov
4.